Subclinical cytomegalovirus reactivation in patients with newly diagnosed or relapsed ANCA-associated vasculitis and adverse clinical outcomes (REACTIVAS)

Project Details

Short titleSubclinical cytomegalovirus reactivation in patients with newly diagnosed or relapsed ANCA-associated vasculitis and adverse clinical outcomes (REACTIVAS)
StatusActive
Effective start/end date1/04/22 → 31/03/25

Funding

  • University Hospital Birmingham NHS Foundation Trust